Quest Biotechnology Inc said its QuestBlood Substitute Inc subsidiary executed an agreement with AlzaCorp &lt;AZA> which will make Alza a preferred shareholder of itssubsidiary.    Quest said the agreement also offers Alza the right toacquire up to 25 pct of the unit's equity in exchange for theacquisition of patent rights to Alza technology in an areawhere Quest has an interest.    Quest also said its signed a merger agreement with &lt;HuntResearch Corp> and its affiliate &lt;ICAS Corp>. Quest said itexpects to complete the merger within the next several weeks. Reuter&#3;